Understanding PSA Scores

0

Just as there is no one-size-fits-all number for high blood pressure, a variety of factors can influence whether a man’s PSA score is considered above normal.

prostate cancer, researchPSA, or prostate-specific antigen, is a protein that’s often associated with prostate cancer. A PSA test measures the level of the protein in a man’s blood. A score of 4.0 (meaning four nanograms of the protein per milliliter of blood) or higher was traditionally defined as abnormal. But as doctors have gotten better at identifying patients likely to develop aggressive forms of prostate cancer, the interpretation of PSA results has become more nuanced.

Today, doctors are likely to take into account an individual’s age, race, and the size of his prostate gland – all of which can affect PSA levels – when interpreting his score. They may also determine how fast PSA levels rise over time, and whether the PSA protein in the bloodstream is bound to other proteins or is free of them.

A variety of other, non-cancerous factors can influence PSA test results. These include an enlarged prostate or an inflamed or infected prostate – all of which tend to raise PSA levels. Some drugs used to treat an enlarged prostate or certain urinary conditions can lower PSA levels, as can certain chemotherapy medications.

Taking all these factors into consideration, doctors now have a better picture of which patients are likely to benefit from further testing, such as a biopsy, for prostate cancer.

“PSA is one of many factors that is considered when determining the need to further screen an individual for prostate cancer via prostate biopsy,” says Rana McKay, MD, of the Genitourinary Cancer Treatment Center at Dana-Farber/Brigham and Women’s Cancer Center. “Before considering PSA testing, it is important to talk to your doctor about your individual risk of developing prostate cancer as well as the risk and benefits of PSA testing.”

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.